Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002912930 | SCV003247717 | uncertain significance | Amyotrophic lateral sclerosis type 1; Perry syndrome; Neuronopathy, distal hereditary motor, type 7B | 2022-10-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DCTN1 protein function. This variant has not been reported in the literature in individuals affected with DCTN1-related conditions. This variant is present in population databases (rs752851562, gnomAD 0.003%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 923 of the DCTN1 protein (p.Pro923Leu). |
Prevention |
RCV003403940 | SCV004118751 | uncertain significance | DCTN1-related disorder | 2023-03-01 | criteria provided, single submitter | clinical testing | The DCTN1 c.2768C>T variant is predicted to result in the amino acid substitution p.Pro923Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-74593138-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ambry Genetics | RCV005321259 | SCV005986172 | uncertain significance | Inborn genetic diseases | 2024-12-25 | criteria provided, single submitter | clinical testing | The c.2768C>T (p.P923L) alteration is located in exon 24 (coding exon 24) of the DCTN1 gene. This alteration results from a C to T substitution at nucleotide position 2768, causing the proline (P) at amino acid position 923 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |